Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Mannosidase Deficiency Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mannosidase deficiency diseases markets are expected to exhibit a CAGR of 11.72% during 2024-2034. The mannosidase deficiency diseases market has been comprehensively analyzed in IMARC's n...

May 2024 135 pages

Mantle Cell Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mantle cell lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5...

May 2024 138 pages

Maple Syrup Urine Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major maple syrup urine disease markets are expected to exhibit a CAGR of 11.2% during 2024-2034. The maple syrup urine disease market has been comprehensively analyzed in IMARC's new report tit...

May 2024 128 pages

Marburg Virus Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major marburg virus disease markets are expected to exhibit a CAGR of 5.5% during 2024-2034. The Marburg virus disease market has been comprehensively analyzed in IMARC's new report titled 'Marb...

May 2024 138 pages

Marfan Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Marfan syndrome markets are expected to exhibit a CAGR of 5.17% during 2024-2034. The Marfan syndrome market has been comprehensively analyzed in IMARC's new report titled 'Marfan Syndrome...

May 2024 130 pages

Marginal Zone Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major marginal zone lymphoma markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Mastocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mastocytosis markets are expected to exhibit a CAGR of 3.41% during 2024-2034. The mastocytosis market has been comprehensively analyzed in IMARC's new report titled 'Mastocytosis Market:...

May 2024 134 pages

Medullary Thyroid Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major medullary thyroid cancer markets reached a value of US$ 141.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 405.1 Million by 2034, exhibiting a growth rate (CA...

May 2024 131 pages

Medulloblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major medulloblastoma markets are expected to exhibit a CAGR of 6.05% during 2024-2034. The medulloblastoma market has been comprehensively analyzed in IMARC's new report titled 'Medulloblastoma...

May 2024 136 pages

Meibomian Gland Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meibomian gland dysfunction markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major melanoma markets reached a value of US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.9 Billion by 2034, exhibiting a growth rate (CAGR) of 7.93% during...

May 2024 135 pages

MELAS Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The MELAS Syndrome market reached a value of US$ 154.8 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 447.7 Million by 203...

May 2024 138 pages

Membranous Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major membranous nephropathy markets reached a value of US$ 125.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 190.5 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 131 pages

Memory Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major memory disorders markets are expected to exhibit a CAGR of 5.42% during 2024-2034. The memory disorders market has been comprehensively analyzed in IMARC's new report titled 'Memory Disord...

May 2024 138 pages

Meniere's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Meniere's disease markets are expected to exhibit a CAGR of 2.38% during 2024-2034. The Meniere's disease market has been comprehensively analyzed in IMARC's new report titled 'Meniere's D...

May 2024 140 pages

Meningioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.79% durin...

May 2024 129 pages

Meningitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningitis markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The meningitis market has been comprehensively analyzed in IMARC's new report titled 'Meningitis Market: Epidemi...

May 2024 131 pages

Menkes Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Menkes disease markets are expected to exhibit a CAGR of 5.88% during 2024-2034. The Menkes disease market has been comprehensively analyzed in IMARC's new report titled 'Menkes Disease Ma...

May 2024 133 pages

Menorrhagia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major menorrhagia markets reached a value of US$ 970 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,380 Million by 2034, exhibiting a growth rate (CAGR) of 3.26% du...

May 2024 137 pages

Merkel Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Merkel cell carcinoma markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mesothelioma markets reached a value of US$ 434.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.91%...

May 2024 133 pages

Metabolic Acidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metabolic acidosis markets are expected to exhibit a CAGR of 5.76% during 2024-2034. The metabolic acidosis market has been comprehensively analyzed in IMARC's new report titled 'Metabolic...

May 2024 140 pages

Metachromatic Leukodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major metachromatic leukodystrophy markets reached a value of US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.2 Billion by 2034, exhibiting a growth rate (CA...

May 2024 133 pages

Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic castration-resistant prostate cancer markets are expected to exhibit a CAGR of 5.44% during 2024-2034. The metastatic castration-resistant prostate cancer market has been compre...

May 2024 138 pages

Metastatic Cutaneous Squamous Cell Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic cutaneous squamous cell cancer markets are expected to exhibit a CAGR of 5.64% during 2024-2034. The metastatic cutaneous squamous cell cancer market has been comprehensively an...

May 2024 140 pages

Metastatic Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic hepatocellular carcinoma markets are expected to exhibit a CAGR of 13.63% during 2024-2034. The metastatic hepatocellular carcinoma market has been comprehensively analyzed in I...

May 2024 135 pages

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic HER2-positive breast cancer markets are expected to exhibit a CAGR of 1.18% during 2024-2034. The metastatic HER2-positive breast cancer market has been comprehensively analyzed...

May 2024 138 pages

Metastatic Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic melanoma markets are expected to exhibit a CAGR of 8.23% during 2024-2034. The metastatic melanoma market has been comprehensively analyzed in IMARC's new report titled 'Metasta...

May 2024 132 pages

Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic prostate cancer markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The metastatic prostate cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Mild Cognitive Impairment Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mild cognitive impairment markets are expected to exhibit a CAGR of 4.02% during 2024-2034. The mild cognitive impairment market has been comprehensively analyzed in IMARC's new report tit...

May 2024 137 pages

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major minimal residual disease markets reached a value of US$ 855.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,261.0 Million by 2034, exhibiting a growth rate (...

May 2024 138 pages

Mitochondrial Myopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mitochondrial myopathies markets reached a value of US$ 22.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Mood Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mood disorders markets reached a value of US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 1.78% d...

May 2024 128 pages

Morquio Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Morquio syndrome markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The Morquio syndrome market has been comprehensively analyzed in IMARC's new report titled 'Morquio Syndr...

May 2024 134 pages

Motor Neuron Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major motor neuron disease markets reached a value of US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Mouth Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mouth neoplasms markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.69%...

May 2024 137 pages

Mucopolysaccharidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mucopolysaccharidoses markets are expected to exhibit a CAGR of 5.9% during 2024-2034. The mucopolysaccharidoses market has been comprehensively analyzed in IMARC's new report titled 'Muco...

May 2024 128 pages

Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The mucopolysaccharidosis market has been comprehensively analyzed in IMARC's new report titled 'Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Fore...

May 2024 138 pages

Multiple Endocrine Neoplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple endocrine neoplasia markets are expected to exhibit a CAGR of 10.2% during 2024-2034. The multiple endocrine neoplasia market has been comprehensively analyzed in IMARC's new repo...

May 2024 132 pages

Multiple System Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple system atrophy markets reached a value of US$ 129.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 187.2 Million by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Muscle Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major muscle spasticity markets reached a value of US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.84...

May 2024 128 pages

Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major musculoskeletal pain markets reached a value of US$ 3,975.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,399.8 Million by 2034, exhibiting a growth rate (CA...

May 2024 134 pages

Myasthenia Gravis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myasthenia gravis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.99...

May 2024 134 pages

Mycosis Fungoides Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mycosis fungoides markets are expected to exhibit a CAGR of 4.9% during 2024-2034. The mycosis fungoides market has been comprehensively analyzed in IMARC's new report titled 'Mycosis Fung...

May 2024 129 pages

Mydriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mydriasis markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The mydriasis market has been comprehensively analyzed in IMARC's new report titled 'Mydriasis Market: Epidemiol...

May 2024 137 pages

Myelodysplastic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myelodysplastic syndrome markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 136 pages

Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocardial infarction markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Myocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocarditis markets reached a value of US$ 1,373.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,281.7 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 131 pages

Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myofascial pain syndromes markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The myofascial pain syndromes market has been comprehensively analyzed in IMARC's new report tit...

May 2024 135 pages

Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myopia markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The myopia market has been comprehensively analyzed in IMARC's new report titled 'Myopia Market: Epidemiology, Indu...

May 2024 138 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...